简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

尽管在强劲的27财年EBITDA增长指引下未能达到2014年底线,Tilray仍上涨

2026-07-29 06:42

  • Tilray Brands (TLRY) is up ~3% in after-hours trading Tuesday after its FQ4 EPS results missed expectations as its full-year EBITDA guidance of $68M-$75M represents double-digit year-over-year growth.
  • Though a miss, in FQ4, Non-GAAP EPS of $0.11 compares to $0.07 in the year-ago period.
  • For FY26 (ended May 31), adjusted EBITDA was $61.1M. That compares to $55M in fiscal 2025.
  • Revenue in Tilray's biggest segment, beverages, grew ~61% YoY to $105.6M. Cannabis revenue rose ~5% to $71.5M.
  • Tilray ended the fiscal year with cash and cash equivalents of ~$226M compared to ~$221.7M at the end of FY25.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。